tradingkey.logo
tradingkey.logo
Search

Estrella Immunopharma Inc

ESLA
Add to Watchlist
0.714USD
-0.006-0.88%
Close 07-31 16:00ETQuotes delayed by 15 min
30.45MMarket Cap
LossP/E TTM

ESLA Financials

See Estrella Immunopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Estrella Immunopharma Inc Earnings Date

Latest Release
May 18, 2026
EPS / Forecast
-0.05/-0.19
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.35
-192.63%
Analyst Rating
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Financial Indicators
EPS
6.41%-0.05
84.16%-0.02
-878.97%-0.13
-428.87%-0.15
-9.43%-0.06
-31.91%-0.10
83.02%-0.01
62.98%-0.03
---0.05
---0.08
---0.08
---0.08
----
Net Profit
-8.92%-2.29M
84.48%-613.17K
-922.54%-4.80M
-443.28%-5.54M
-12.50%-2.10M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
---2.73M
---2.74M
---2.76M
---2.89M
Debt to assets ratio
----
----
----
----
----
----
----
----
--1.10%
----
----
----
----
Operating profit
-8.92%-2.29M
84.47%-613.20K
-922.54%-4.80M
-443.20%-5.54M
-12.50%-2.10M
-44.59%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
---2.73M
---2.74M
---2.76M
---2.89M
Net Profit
-8.92%-2.29M
84.48%-613.17K
-922.54%-4.80M
-443.28%-5.54M
-12.50%-2.10M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
---2.73M
---2.74M
---2.76M
---2.89M
Current assets
-3.49%2.16M
-62.35%1.68M
-89.06%944.27K
-84.33%1.48M
-91.83%2.24M
61.84%4.45M
203.41%8.63M
--9.45M
--27.35M
--2.75M
--2.85M
----
----
Total current liabilities
198.69%8.93M
7394.72%13.54M
2987.00%4.28M
2176.01%9.08M
-82.70%2.99M
-98.15%180.70K
-98.07%138.49K
--398.73K
--17.28M
--9.76M
--7.19M
----
----
Total assets
-2.09%3.66M
-28.67%3.18M
-71.69%2.44M
-68.45%2.98M
-86.34%3.74M
47.08%4.45M
178.39%8.63M
--9.45M
--27.35M
--3.03M
--3.10M
----
----
Total liabilities
198.69%8.93M
7394.72%13.54M
2987.00%4.28M
2176.01%9.08M
-82.70%2.99M
-98.15%180.70K
-98.08%138.49K
--398.73K
--17.28M
--9.77M
--7.22M
----
----
Total equity
-806.20%-5.27M
-342.57%-10.37M
-121.55%-1.83M
-167.36%-6.09M
-92.59%746.29K
163.38%4.27M
306.49%8.49M
--9.05M
--10.07M
---6.74M
---4.11M
----
----
Net operating income
-1337.40%-6.70M
39.12%-177.49K
82.82%-727.33K
96.32%-414.88K
-69.33%-465.98K
-574.10%-291.51K
-4914.13%-4.23M
-10313.48%-11.27M
74.99%-275.19K
---43.24K
---84.45K
---108.20K
---1.10M
Net investment
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
--5.07M
---112.30K
---136.53K
---136.53K
--0.00
--0.00
Net financing
24677.80%7.24M
76.02%-64.82K
1333.60%1.04M
118.99%1.31M
-100.15%-29.46K
---270.35K
---84.09K
---6.90M
--20.05M
----
----
--0.00
--0.00

FAQs

What are the current assets of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its current assets were 1.68M, with a year-on-year change of 2.21.

What are the total assets of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its total assets of Estrella Immunopharma Inc were 3.18M, with a year-on-year change of 1.15.

What are the total liabilities of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its total liabilities of Estrella Immunopharma Inc were 13.54M, with a year-on-year change of 351.88.

What is the total equity of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its total equity of Estrella Immunopharma Inc was -10.37M, with a year-on-year change of -7312.12.

What is the net operating income of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its net operating income of Estrella Immunopharma Inc was -13.06M, with a year-on-year change of -195.07.

What is the net financing of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its net financing of Estrella Immunopharma Inc was 2.25M, with a year-on-year change of 1769.11.

What is the Earnings Per Share (EPS) of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.35, with a year-on-year change of -192.63.

What is the net income of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its net income was -13.06M, with a year-on-year change of -195.09.

What is the operating profit of Estrella Immunopharma Inc?

According to Estrella Immunopharma Inc's FY2025 earnings report, its operating profit was -13.06M, with a year-on-year change of -195.07.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.